Lars Christian Wilde is the President, Chief Business Officer and Co‑founder of Compass Pathways. In September 2020 the company went public, listing their stock on Nasdaq and raising $146.6 million. Compass is a “mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.” Compass was one of the first companies engaging in a bigger vision of the substance psilocybin. Wilde speaks about his treatment with psilocybin, that helped him tremendously to begin a new life with a different mental health set.
Learn how Compass works with the Charité hospital in Berlin to conduct the study COMP360, a psilocybin therapy trial for treatment-resistant depression.